Sarepta Therapeutics, Inc. (SRPT) was raised to ‘Outperform’ from ‘Neutral’ and it was given $36 price target at Wedbush on …
View the full post at: Notable Analyst Calls: Sarepta Therapeutics (SRPT), Biogen Inc. (BIIB), Regulus Therapeutics (RGLS), Western Digital Corporation (WDC)